The significance of "indefinite for dysplasia" grading in Barrett metaplasia

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 4, 2011, Pages 430-432

  Younes, Mamoun ^a   Lauwers, Gregory Y ^b   Ertan, Atilla ^a,c   Ergun, Gulchin ^a   Verm, Ray ^a   Bridges, Margaret ^a   Woods, Karen ^c   Meriano, Frank ^c   Schmulen, Carl ^a,c   Johnson, Craig ^a   Barroso, Alberto ^c   Schwartz, Jim ^a   McKechnie, John ^c   Lechago, Juan ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Methodist Hospital   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; DISEASE COURSE; ESOPHAGUS; ESOPHAGUS TUMOR; HUMAN; PATHOLOGY; PRECANCER; PROGNOSIS; PROSPECTIVE STUDY;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; PRECANCEROUS CONDITIONS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 79955116960     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002;97(8):1888-1895.
2. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 1994;25(10):982-993.
3. Younes M, Lechago J, Chakraborty S, et al. Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Gluti overexpression in Barrett metaplasia. Scand J Gastroenterol. 2000;35(2):131-137. (Pubitemid 30216580)
4. Amano Y, Kushiyama Y, Yuki T, et al. Predictors for squamous reepithelialization of Barrett's esophagus after endoscopic biopsy. J Gastroenterol Hepatol. 2007;22(6):901-907. (Pubitemid 46911011)
5. Ban S, Mino M, Nishioka NS, et al. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Am I Surg Pathol. 2004;28(11):1466-1473. (Pubitemid 39425513)
6. Etienne J, Dorme N, Bourg-Heckly G, Raimbert P, Flejou JF. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus [published correction appears in Gastrointest Endosc. 2004;60(6):1042]. Gastrointest Endosc. 2004;59(7):880-889. (Pubitemid 38879323)
7. Kelty CJ, Ackroyd R, Brown NJ, Brown SB, Reed MW. Comparison of highvs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus. Surg Endosc. 2004;18(3):452-458. (Pubitemid 38524516)
8. Lomo LC, Blount PL, Sanchez CA, et al. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. Am J Surg Pathol. 2006;30(4):423-435. (Pubitemid 43740142)
9. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol. 1988;19(2):166-178. (Pubitemid 18091022)
10. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001; 32(4):368-378. (Pubitemid 32378298)